List of Contract Research Stocks
Contract Research is part of the Pharma Services group in the Healthcare sector. Its 43 US-listed companies are worth $480.16 billion between them. The median is $503.31 million. 12 have Contract Research as their primary business, and 31 more run a substantial one alongside another industry.
|
List of Contract Research Stocks
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Company | Mkt Cap | Price | Chg % | 1Y | Revenue (TTM) | Net Income (TTM) | P/E | Revenue Growth (1y) (TTM)% | Net Margin (TTM)% | Div. Yield% | Why this company is listed here |
| TMO 2nd | Thermo Fisher Scientific | $250.84Bn | 678.40 | +0.70% | +46.83% | 46.34Bn | 6.99Bn | 36.13 | 7.23 | 15.04 | 0.27 | |
| IQV | Iqvia Holdings | $44.55Bn | 270.68 | +0.35% | +49.78% | 16.98Bn | 1.38Bn | 32.70 | 8.17 | 8.10 | — | |
| LH 2nd | Labcorp Holdings | $25.04Bn | 309.57 | +0.04% | +9.49% | 14.35Bn | 1.00Bn | 25.23 | 6.41 | 6.99 | 0.93 | |
| GH 2nd | Guardant Health | $23.69Bn | 177.33 | +0.05% | +186.06% | 1.18Bn | -453.44Mn | -51.96 | 42.74 | -38.33 | — | |
| MEDP | Medpace Holdings | $17.19Bn | 615.94 | -0.48% | +23.00% | 2.78Bn | 491.50Mn | 35.31 | 24.67 | 17.67 | — | |
| LDOS 2nd | Leidos Holdings | $15.36Bn | 122.38 | -1.02% | -34.07% | 17.63Bn | 1.40Bn | 11.21 | 3.41 | 7.80 | 1.41 | |
| TEM 2nd | Tempus AI | $14.91Bn | 85.08 | +0.08% | +8.29% | 1.43Bn | -246.84Mn | -60.16 | 50.43 | -17.77 | 0.00 | |
| CRL | Charles River Laboratories International | $14.06Bn | 294.68 | +0.51% | +100.48% | 4.00Bn | -236.30Mn | -59.34 | -0.74 | -5.96 | — | |
| ICLR | Icon | $13.44Bn | 175.57 | +1.88% | +7.42% | 8.25Bn | 93.48Mn | 41.87 | 1.31 | 3.99 | — | |
| DVA 2nd | Davita | $11.39Bn | 178.03 | -0.24% | +36.33% | 14.01Bn | 1.19Bn | 13.61 | 6.45 | 6.05 | — | |
| TWST 2nd | Twist Bioscience | $11.26Bn | 179.60 | -1.77% | +565.19% | 431.80Mn | -136.73Mn | -81.93 | 19.19 | -31.68 | — | |
| RDY 2nd | Dr Reddys Laboratories | $10.44Bn | 12.51 | +2.04% | -10.45% | 3.66Bn | 4.44Bn | 0.06 | -6.71 | 4,658.34 | 0.64 | |
| CAI 2nd | Caris Life Sciences | $8.97Bn | 31.75 | -0.72% | +5.83% | 989.61Mn | 105.14Mn | 85.43 | 85.37 | 10.62 | 0.00 | |
| ADPT 2nd | Adaptive Biotechnologies | $4.53Bn | 28.51 | -3.13% | +111.81% | 308.08Mn | -63.99Mn | -71.37 | 50.13 | -20.73 | — | |
| ABCL 2nd | AbCellera Biologics | $4.27Bn | 13.92 | +9.61% | +185.83% | 66.17Mn | -164.66Mn | -25.83 | — | -248.83 | — | |
| NEO 2nd | Neogenomics | $2.47Bn | 19.29 | -0.21% | +148.26% | 766.30Mn | -51.88Mn | -48.20 | 11.19 | -6.77 | — | |
| FTRE | Fortrea Holdings | $1.91Bn | 20.06 | +0.85% | +138.81% | 2.68Bn | -85.20Mn | -22.32 | -2.09 | -3.18 | — | |
| OABI 2nd | OmniAb | $689.15Mn | 4.74 | +2.82% | +194.41% | 38.46Mn | -44.27Mn | -13.79 | 67.01 | -115.12 | — | |
| STLN 2nd | Starling Oncology | $667.11Mn | 6.64 | -0.30% | +91.91% | 587.24Mn | -36.29Mn | -22.41 | 38.38 | -5.20 | — | |
| DNA | Ginkgo Bioworks Holdings | $665.78Mn | 10.45 | -1.97% | -21.01% | 111.86Mn | -290.80Mn | -2.23 | -46.80 | -259.96 | — | |
| EVO | Evotec SE | $565.34Mn | 1.59 | +2.58% | -55.08% | — | — | — | — | — | 0.00 | |
| YDES 2nd | YD Bio | $503.31Mn | 7.11 | +24.08% | -60.65% | — | — | — | — | — | — | |
| CLPT 2nd | ClearPoint Neuro | $467.00Mn | 15.31 | +3.24% | -29.02% | 42.28Mn | -34.57Mn | -13.36 | 25.86 | -81.76 | — | |
| WDH 2nd | Waterdrop | $371.71Mn | 1.03 | -1.90% | -46.63% | 732.27Mn | 56.59Mn | 6.57 | 76.34 | 7.74 | 5.83 | |
| BDSX 2nd | Biodesix | $320.93Mn | 30.42 | +4.54% | +293.02% | 102.94Mn | -28.70Mn | -11.28 | 34.46 | -26.97 | — | |
| IMRX 2nd | Immuneering | $269.14Mn | 4.16 | -2.58% | -38.37% | — | -58.75Mn | -4.70 | — | — | — | |
| AGPU 2nd | Axe Compute | $239.18Mn | 12.15 | +0.50% | -32.50% | — | -253.50Mn | -0.94 | — | — | — | |
| XGN 2nd | Exagen | $205.16Mn | 8.48 | -2.75% | -21.26% | 71.12Mn | -18.92Mn | -10.83 | 20.83 | -26.61 | — | |
| BNR 2nd | Burning Rock Biotech | $185.44Mn | 17.63 | -5.22% | +87.75% | 72.00Mn | -11.19Mn | -16.03 | -3.58 | -13.60 | — | |
| KRMD 2nd | KORU Medical Systems | $141.21Mn | 3.06 | -4.67% | -20.31% | 45.11Mn | -1.82Mn | -77.51 | 22.41 | -4.03 | — | |
| MXCT 2nd | Maxcyte | $123.12Mn | 1.16 | -0.85% | -22.67% | 31.05Mn | -35.64Mn | -3.48 | — | -114.77 | — | |
| IMDX 2nd | Insight Molecular Diagnostics | $103.74Mn | 3.18 | -18.88% | -1.55% | 1.67Mn | -49.36Mn | -2.37 | -60.77 | -2,955.63 | — | |
| NTRB 2nd | NutriBand | $100.04Mn | 8.23 | +2.87% | +16.57% | 1.62Mn | -6.96Mn | -14.37 | -37.25 | -430.43 | — | |
| CSBR | Champions Oncology | $68.06Mn | 4.89 | -0.20% | -23.35% | 60.66Mn | -1.14Mn | -61.56 | 6.65 | -1.82 | — | |
| XBIT 2nd | XBiotech | $65.55Mn | 2.15 | -0.92% | -20.07% | — | -41.38Mn | -1.58 | — | — | 0.00 | |
| HYFT | MindWalk Holdings | $62.59Mn | 1.34 | -2.90% | -22.54% | 11.72Mn | -12.33Mn | -5.05 | 5.69 | -105.10 | — | |
| BFRG 2nd | BullFrog AI Holdings | $12.24Mn | 0.66 | -1.49% | -52.17% | 332.06K | -5.89Mn | -2.12 | — | -1,762.37 | — | |
| PBSV 2nd | Pharma-Bio Serv | $8.02Mn | 0.35 | -20.45% | -46.15% | 9.48Mn | -154.94K | 31.87 | 3.25 | 2.65 | 20.00 | |
| VSBC 2nd | Vitaspring Biomedical | $2.07Mn | 0.01 | +0.00% | -99.00% | — | -455.64K | -4.53 | — | — | — | |
| VIVS | VivoSim Labs | $1.15Mn | 0.22 | +0.00% | -92.72% | 112.00K | -11.13Mn | -0.09 | — | -11,016.07 | — | |
| CPMV 2nd | Mosaic ImmunoEngineering | $434.53K | 0.06 | +0.00% | -92.21% | — | -681.88K | -0.64 | — | — | 0.00 | |
| NOTVQ | Inotiv | $348.88K | 0.01 | +0.00% | — | 507.36Mn | -86.97Mn | 0.00 | 5.61 | -17.14 | — | |
| CBIH | Cannabis Bioscience International Holdings | $0.00 | 0.00 | — | — | — | — | — | — | — | — | |
Showing 30 of 43 Contract Research companies
Create a free account to see the remaining 13, sort the full list on any column, and choose your own metrics.
Free, no card. Already have an account? Sign in.
No companies match that filter.
- 2nd a substantial business here, but not the company’s largest
- Prices and market caps as of the last close
- Click any column heading to sort
About this list
How many Contract Research stocks are there?
This list holds 43 US-listed companies, of which 12 have Contract Research as their primary business. The rest operate a substantial Contract Research business alongside something else, which is why they appear here as well as on their own primary list.
How is this list put together?
Every US-listed company is classified under BQ-MICS, our own multi-industry classification system. Unlike a single-label scheme it assigns each company a primary industry AND any secondary industries it genuinely operates in, and it records the reasoning behind every assignment — which you can read on each row of the table above.
Why do some companies appear on more than one list?
Because they genuinely operate more than one business. A retailer running a large cloud division belongs on both lists, and a classification that forces it onto one is hiding half the company. Every appearance beyond the primary one is labelled as secondary, and the toggle above the table hides them if you only want pure plays.
How often is this list updated?
Prices, market caps and performance figures refresh with each session's close. The classification itself is reviewed whenever a company's filings change what it does — a new segment, a disposal or an acquisition — rather than on a fixed calendar.
Can I screen these companies on other metrics?
Yes. Use Edit Columns above the table to add any of 1,000+ financial metrics and ratios to this list, or open the full stock screener to filter the whole market on them.